These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36806646)

  • 21. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials.
    Elewski BE; Cáceres HW; DeLeon L; El Shimy S; Hunter JA; Korotkiy N; Rachesky IJ; Sanchez-Bal V; Todd G; Wraith L; Cai B; Tavakkol A; Bakshi R; Nyirady J; Friedlander SF
    J Am Acad Dermatol; 2008 Jul; 59(1):41-54. PubMed ID: 18378354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The evolving role of itraconazole, fluconazole and terbinafine in the treatment of tinea capitis.
    Friedlander SF
    Pediatr Infect Dis J; 1999 Feb; 18(2):205-10. PubMed ID: 10048703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iranian National Survey on Tinea Capitis: Antifungal Susceptibility Profile, Epidemiological Characteristics, and Report of Two Strains with a Novel Mutation in SQLE Gene with Homology Modeling.
    Abastabar M; Babaei M; Mohammadi R; Valadan R; Javidnia J; Zaedi A; Aghili SR; Haghani I; Khojasteh S; Reazaei-Matehkolaei A; Kiasat N; Hesari KK; Ghasemi Z; Azish M; Zarrinfar H; Taghizadeh-Armaki M; Keikha N; Kharazi M; Khodadadi H; Hedayati MT; Shokohi T
    Mycopathologia; 2023 Oct; 188(5):449-460. PubMed ID: 35980496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of tinea capitis in Israel: A comparative study.
    Shemer A; Gupta AK; Galili E; Daniel R; Kassem R; Farhi R; Grunwald H; Bamimore MA
    Pediatr Dermatol; 2021 Jul; 38(4):806-811. PubMed ID: 33998709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo.
    Mock M; Monod M; Baudraz-Rosselet F; Panizzon RG
    Dermatology; 1998; 197(4):361-7. PubMed ID: 9873175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tinea capitis.
    Alvarez MS; Silverberg NB
    Cutis; 2006 Sep; 78(3):189-96. PubMed ID: 17036663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China.
    Deng S; Hu H; Abliz P; Wan Z; Wang A; Cheng W; Li R
    Mycopathologia; 2011 Nov; 172(5):365-72. PubMed ID: 21701791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guidelines for the management of tinea capitis in children.
    Kakourou T; Uksal U;
    Pediatr Dermatol; 2010; 27(3):226-8. PubMed ID: 20609140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic antifungal therapy for tinea capitis in children: An abridged Cochrane Review.
    Chen X; Jiang X; Yang M; Bennett C; González U; Lin X; Hua X; Xue S; Zhang M
    J Am Acad Dermatol; 2017 Feb; 76(2):368-374. PubMed ID: 27816294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tinea capitis.
    Gupta AK; Summerbell RC
    Med Mycol; 2000 Aug; 38(4):255-87. PubMed ID: 10975696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of scalp ringworm.
    Drug Ther Bull; 1996 Jan; 34(1):5-6. PubMed ID: 8746192
    [No Abstract]   [Full Text] [Related]  

  • 32. Tinea capitis: epidemiology, diagnosis and management strategies.
    Pomeranz AJ; Sabnis SS
    Paediatr Drugs; 2002; 4(12):779-83. PubMed ID: 12431130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tinea Capitis: An Updated Review.
    Leung AKC; Hon KL; Leong KF; Barankin B; Lam JM
    Recent Pat Inflamm Allergy Drug Discov; 2020; 14(1):58-68. PubMed ID: 31906842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The kerion: an angry tinea capitis.
    John AM; Schwartz RA; Janniger CK
    Int J Dermatol; 2018 Jan; 57(1):3-9. PubMed ID: 27696388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric tinea capitis caused by Trichophyton violaceum and Trichophyton soudanense in Rochester, Minnesota, United States.
    Grigoryan KV; Tollefson MM; Olson MA; Newman CC
    Int J Dermatol; 2019 Aug; 58(8):912-915. PubMed ID: 30548845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [How to cope with tinea capitis?].
    Lateur N
    Rev Med Brux; 2004 Jun; 25(3):148-52. PubMed ID: 15291446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tinea in Tots: Cases and Literature Review of Oral Antifungal Treatment of Tinea Capitis in Children under 2 Years of Age.
    Zampella JG; Kwatra SG; Blanck J; Cohen B
    J Pediatr; 2017 Apr; 183():12-18.e3. PubMed ID: 28088394
    [No Abstract]   [Full Text] [Related]  

  • 38. Microsporum canis infections in children: results of a new oral antifungal therapy.
    Ginter G
    Mycoses; 1996; 39(7-8):265-9. PubMed ID: 9009643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing the therapeutic approach in tinea capitis of childhood with itraconazole.
    Möhrenschlager M; Schnopp C; Fesq H; Strom K; Beham A; Mempel M; Thomsen S; Brockow K; Wessner DB; Heidelberger A; Ruhdorfer S; Weigl L; Seidl HP; Ring J; Abeck D
    Br J Dermatol; 2000 Nov; 143(5):1011-5. PubMed ID: 11069511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tinea capitis: diagnostic criteria and treatment options.
    Meadows-Oliver M
    Dermatol Nurs; 2009; 21(5):281-6. PubMed ID: 19873694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.